Tolero Pharmaceuticals Presents Data Demonstrating Profound Synergy of Alvocidib and Bromodomain Protein Inhibitors in Nonclinical Models of Acute Myeloid Leukemia
Glu Mobile Announces New Employment Inducement Awards
VisualDx Mobile App Hits 100 Million Image Views Milestone
UPDATE: Russia nervously eyes the U.S.-Iran deal
Professional Development Academy Closes IT Leadership Gap
Amid soaring prices, financial planners need a role in solving what ails U.S. universities.
Euronav NV Announces Final Results 2014 and New Dividend Policy
Rekenthaler drop-kicks PBS' documentary.
Prudent Investor Advisors' Scott Simon offers thoughts on the recent PBS' Frontline broadcast.
After reviewing Avon's AVP most recent annual report, as well as recent investor presentations, we are raising our fair value estimate for the firm's shares. Avon's turnaround is finally gaining traction, and while it has taken slightly longer than we expected to reach this point, we now see more ...